MDA Applauds Expanded US FDA Approval of ELEVIDYS Gene Therapy for DMD Patients Ages 4 and Above

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

New Directions in Friedreich Ataxia

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Thursday, May 18, 2023


David Lynch, MD, PhD
Division of Neurology
Children’s Hospital of Philadelphia
Activity Overview: 

This webinar, featuring David Lynch, MD, PhD, of Children’s Hospital of Philadelphia, will provide updates on the evolving Friedreich Ataxia (FRDA) treatment landscape and briefly discuss the status of FRDA understanding, diagnosis, and research.

Download Clinician Flashcard